The closing price of Rani Therapeutics Holdings Inc (NASDAQ: RANI) was $3.11 for the day, up 2.64% from the previous closing price of $3.03. In other words, the price has increased by $+0.0800 from its previous closing price. On the day, 128133 shares were traded.
Ratios:
Our analysis of RANI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.33 and its Current Ratio is at 6.33. In the meantime, Its Debt-to-Equity ratio is 2.34 whereas as Long-Term Debt/Eq ratio is at 1.90.
On October 11, 2022, UBS started tracking the stock assigning a Buy rating and target price of $15.
On July 27, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $22.H.C. Wainwright initiated its Buy rating on July 27, 2022, with a $22 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 06 ’23 when Imran Talat bought 10,000 shares for $2.27 per share. The transaction valued at 22,700 led to the insider holds 484,455 shares of the business.
Imran Talat bought 5,000 shares of RANI for $12,850 on Dec 04 ’23. The Chief Executive Officer now owns 474,455 shares after completing the transaction at $2.57 per share. On Nov 29 ’23, another insider, Imran Talat, who serves as the Chief Executive Officer of the company, bought 20,000 shares for $2.05 each. As a result, the insider paid 41,000 and bolstered with 469,455 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RANI now has a Market Capitalization of 78.90M and an Enterprise Value of 60.46M.
Stock Price History:
The Beta on a monthly basis for RANI is 0.91, which has changed by -40.24% over the last 52 weeks, in comparison to a change of 29.57% over the same period for the S&P500. Over the past 52 weeks, RANI has reached a high of $5.81, while it has fallen to a 52-week low of $1.82. The 50-Day Moving Average of the stock is 3.4866, while the 200-Day Moving Average is calculated to be 3.2714.
Shares Statistics:
RANI traded an average of 79.32K shares per day over the past three months and 68.62k shares per day over the past ten days. A total of 26.04M shares are outstanding, with a floating share count of 11.50M. Insiders hold about 55.82% of the company’s shares, while institutions hold 7.73% stake in the company. Shares short for RANI as of Mar 15, 2024 were 1.86M with a Short Ratio of 23.47, compared to 1.67M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.15% and a Short% of Float of 13.71%.
Earnings Estimates
The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of -$0.2 for the current quarter, with a high estimate of -$0.14 and a low estimate of -$0.24, while EPS last year was -$0.33. The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.14 and low estimates of -$0.22.
Analysts are recommending an EPS of between -$0.58 and -$1 for the fiscal current year, implying an average EPS of -$0.82. EPS for the following year is -$0.66, with 3 analysts recommending between -$0.46 and -$0.82.
